Literature DB >> 12417296

PSF and p54(nrb)/NonO--multi-functional nuclear proteins.

Yaron Shav-Tal1, Dov Zipori.   

Abstract

Proteins are often referred to in accordance with the activity with which they were first associated or the organelle in which they were initially identified. However, a variety of nuclear factors act in multiple molecular reactions occurring simultaneously within the nucleus. This review describes the functions of the nuclear factors PSF (polypyrimidine tract-binding protein-associated splicing factor) and p54(nrb)/NonO. PSF was initially termed a splicing factor due to its association with the second step of pre-mRNA splicing while p54(nrb)/NonO was thought to participate in transcriptional regulation. Recent evidence shows that the simplistic categorization of PSF and its homolog p54(nrb)/NonO to any single nuclear activity is not possible and in fact these proteins exhibit multi-functional characteristics in a variety of nuclear processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417296     DOI: 10.1016/s0014-5793(02)03447-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  157 in total

1.  An actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II.

Authors:  Piergiorgio Percipalle; Nathalie Fomproix; Karin Kylberg; Francesc Miralles; Birgitta Bjorkroth; Bertil Daneholt; Neus Visa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

2.  p54(nrb) associates with the 5' splice site within large transcription/splicing complexes.

Authors:  Sei Kameoka; Paula Duque; Maria M Konarska
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

3.  Regulation of DNA Topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U).

Authors:  Shinji Kawano; Mary Miyaji; Shoko Ichiyasu; Kimiko M Tsutsui; Ken Tsutsui
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

4.  p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock.

Authors:  Guadalupe Sabio; María I Cerezo-Guisado; Paloma Del Reino; Francisco A Iñesta-Vaquera; Simon Rousseau; J Simon C Arthur; David G Campbell; Francisco Centeno; Ana Cuenda
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

5.  PSF controls expression of histone variants and cellular viability in thymocytes.

Authors:  Florian Heyd; Kristen W Lynch
Journal:  Biochem Biophys Res Commun       Date:  2011-10-06       Impact factor: 3.575

6.  An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins.

Authors:  Erik M Lenarcic; Benjamin J Ziehr; Nathaniel J Moorman
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

7.  The growing pre-mRNA recruits actin and chromatin-modifying factors to transcriptionally active genes.

Authors:  Mikael Sjölinder; Petra Björk; Emilia Söderberg; Nafiseh Sabri; Ann-Kristin Ostlund Farrants; Neus Visa
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  Roles of PSF protein and VL30 RNA in reversible gene regulation.

Authors:  Xu Song; Ying Sun; Alan Garen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

9.  TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.

Authors:  Cheng Zhang; Ming-Xiang Zhang; Ying H Shen; Jared K Burks; Yun Zhang; Jian Wang; Scott A LeMaire; Koichi Yoshimura; Hiroki Aoki; Joseph S Coselli; Xing Li Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-03       Impact factor: 8.311

10.  The adapter protein Nck: role of individual SH3 and SH2 binding modules for protein interactions in T lymphocytes.

Authors:  Marcus Lettau; Jennifer Pieper; Alyn Gerneth; Beate Lengl-Janssen; Matthias Voss; Andreas Linkermann; Hendrik Schmidt; Christoph Gelhaus; Matthias Leippe; Dieter Kabelitz; Ottmar Janssen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.